Germany's Evonik rejects BASF's $11.7 billion bid, sources say https://t.co/rsushc9hIk https://t.co/rsushc9hIk
Why now
Thesis: Rejected bid leaves European chemicals M&A unresolved
Catalyst to watch: Revised offer or formal withdrawal
Main risk: Deal collapse removes any premium
Why it matters
A rejected $11.7B bid signals consolidation interest in European chemicals, but the rejection leaves the outcome and any deal premium unresolved.
Details
Germany's Evonik rejects BASF's $11.7 billion bid, sources say https://t.co/rsushc9hIk https://t.co/rsushc9hIk
Related assets & topics
EuropeSources
- x · 2026-09-28 19:00 UTC